Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $33.6B |
| FY2017, ended Dec 31, 2017 | $41.1B |
| FY2018, ended Dec 31, 2018 | $42.8B |
| FY2019, ended Dec 31, 2019 | $51.2B |
| FY2020, ended Dec 31, 2020 | $64.8B |
| FY2021, ended Dec 31, 2021 | $76.8B |
| FY2022, ended Dec 31, 2022 | $57.3B |
| FY2023, ended Dec 31, 2023 | $73.5B |
| FY2024, ended Dec 31, 2024 | $85.6B |
| FY2025, ended Dec 31, 2025 | $92.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $69.1B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.97B |
| FY2017, ended Dec 31, 2017 | $5.84B |
| FY2018, ended Dec 31, 2018 | $6.28B |
| FY2019, ended Dec 31, 2019 | $6.55B |
| FY2020, ended Dec 31, 2020 | $8.24B |
| FY2021, ended Dec 31, 2021 | $9.17B |
| FY2022, ended Dec 31, 2022 | $9.64B |
| FY2023, ended Dec 31, 2023 | $9.90B |
| FY2024, ended Dec 31, 2024 | $11.8B |
| FY2025, ended Dec 31, 2025 | $12.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $13.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.43B | $1.90B |
| FY2017, ended Dec 31, 2017 | $2.53B | $1.86B |
| FY2018, ended Dec 31, 2018 | $1.99B | $2.40B |
| FY2019, ended Dec 31, 2019 | $1.93B | $2.51B |
| FY2020, ended Dec 31, 2020 | $2.09B | $2.67B |
| FY2021, ended Dec 31, 2021 | $4.06B | $2.94B |
| FY2022, ended Dec 31, 2022 | $1.45B | $3.33B |
| FY2023, ended Dec 31, 2023 | $2.37B | $3.35B |
| FY2024, ended Dec 31, 2024 | $2.75B | $4.20B |
| FY2025, ended Dec 31, 2025 | $3.31B | $4.29B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.04B | $5.08B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.35B |
| FY2017, ended Dec 31, 2017 | $535M |
| FY2018, ended Dec 31, 2018 | $724M |
| FY2019, ended Dec 31, 2019 | $841M |
| FY2020, ended Dec 31, 2020 | $583M |
| FY2021, ended Dec 31, 2021 | $607M |
| FY2022, ended Dec 31, 2022 | $1.80B |
| FY2023, ended Dec 31, 2023 | $899M |
| FY2024, ended Dec 31, 2024 | $844M |
| FY2025, ended Dec 31, 2025 | $837M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.07B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.36B |
| FY2017, ended Dec 31, 2017 | $7.93B |
| FY2018, ended Dec 31, 2018 | $8.39B |
| FY2019, ended Dec 31, 2019 | $10.4B |
| FY2020, ended Dec 31, 2020 | $18.9B |
| FY2021, ended Dec 31, 2021 | $15.4B |
| FY2022, ended Dec 31, 2022 | $18.1B |
| FY2023, ended Dec 31, 2023 | $24.6B |
| FY2024, ended Dec 31, 2024 | $23.4B |
| FY2025, ended Dec 31, 2025 | $20.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $21.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 5.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 595M |
| FY2017, ended Dec 31, 2017 | 582M |
| FY2018, ended Dec 31, 2018 | 568M |
| FY2019, ended Dec 31, 2019 | 553M |
| FY2020, ended Dec 31, 2020 | 562M |
| FY2021, ended Dec 31, 2021 | 562M |
| FY2022, ended Dec 31, 2022 | 559M |
| FY2023, ended Dec 31, 2023 | 573M |
| FY2024, ended Dec 31, 2024 | 575M |
| FY2025, ended Dec 31, 2025 | 568M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 561M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $50.0M | $124M | — |
| FY2017, ended Dec 31, 2017 | $949M | $135M | — |
| FY2018, ended Dec 31, 2018 | $1.20B | $130M | — |
| FY2019, ended Dec 31, 2019 | $1.46B | $139M | — |
| FY2020, ended Dec 31, 2020 | $1.25B | $139M | $1.90B |
| FY2021, ended Dec 31, 2021 | $250M | $188M | — |
| FY2022, ended Dec 31, 2022 | $632M | $155M | — |
| FY2023, ended Dec 31, 2023 | $0 | $257M | $1.27B |
| FY2024, ended Dec 31, 2024 | $0 | $231M | — |
| FY2025, ended Dec 31, 2025 | $1.29B | $238M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.00B | $268M | — |
Valuation
At current price- Market Cap
- $87.3B
- P/E
- 21.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.5×
- Price / Book
- 3.0×
- EV / EBITDA
- 15.3×
Growth
Trailing 12 months- Revenue (TTM)
- $13.4B
- Revenue Growth YoY
- 6.9%
- Revenue CAGR 3Y
- 9.5%
- Revenue CAGR 5Y
- 8.9%
- EPS Growth YoY
- 36.1%
- Net Income Growth YoY
- 34.5%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 40.7%
- Net Margin
- 30.1%
- FCF Margin
- 37.8%
- Return on Equity
- 13.9%
Earnings
Trailing 12 months- Net Income
- $4.04B
- EPS (diluted)
- $7.09
- EBITDA
- $7.02B
- Operating Income
- $5.47B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $1.07B
- Total Debt
- $21.1B
- Net Debt
- $20.0B
- Total Assets
- $174B
- Total Liabilities
- $145B
- Shareholders' Equity
- $29.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.51B
- Capital Expenditure
- $436M
- Free Cash Flow
- $5.08B
Dividends and risk
Last 12 months- Dividend Yield
- 1.3%
- Dividend / Share
- $2.04
- Beta (5Y)
- 0.94
Every ratio is calculated from the company’s reported figures.